Literature DB >> 2430458

Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

S S Tabibzadeh, M A Gerber, P G Satyaswaroop.   

Abstract

Recent studies suggest that HLA-DR antigens may be inducible in some normal epithelial cells. Therefore, we studied the expression of these molecules in epithelial cell cultures derived from 9 proliferative and 7 secretory endometria with and without treatment by recombinant gamma-interferon (gamma-IFN). A panel of monoclonal antibodies to HLA-DR antigens, T cells, B cells, macrophages, endothelial cells, and cytokeratin was used to stain the cultured cells by the avidin-biotin complex method. The cultures consisted only of epithelial cells as demonstrated by expression of cytokeratin and by electron microscopy and did not contain any T or B cells, macrophages, or endothelial cells. The endometrial epithelial cells were HLA-DR-negative under routine culture conditions but expressed HLA-DR antigens after gamma-IFN treatment in a dose- and time-dependent fashion. The findings indicate that endometrial epithelium can actively synthesize HLA-DR antigens in vitro after induction by gamma-IFN.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430458      PMCID: PMC1888430     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Applicability of imprints to immuno-ultrastructural studies of lymphoid tissues.

Authors:  S S Tabibzadeh; M A Gerber
Journal:  J Histochem Cytochem       Date:  1985-09       Impact factor: 2.479

2.  Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.

Authors:  B Berman; M R Duncan; B Smith; V A Ziboh; M Palladino
Journal:  J Invest Dermatol       Date:  1985-01       Impact factor: 8.551

3.  Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes.

Authors:  T Y Basham; B J Nickoloff; T C Merigan; V B Morhenn
Journal:  J Interferon Res       Date:  1985

4.  Endometrial lymphoid tissue: an immunohistological study.

Authors:  H Morris; J Edwards; A Tiltman; M Emms
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

5.  The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia.

Authors:  R Schwarting; H Stein; C Y Wang
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

6.  Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody.

Authors:  W E Beschorner; C I Civin; L C Strauss
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

7.  Monoclonal antibodies against human Ia antigens stimulate monocytes to secrete interleukin 1.

Authors:  R Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.

Authors:  G Gastl; C Marth; E Leiter; C Gattringer; I Mayer; G Daxenbichler; R Flener; C Huber
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

9.  Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells.

Authors:  M Londei; J R Lamb; G F Bottazzo; M Feldmann
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  The in vitro regulation of human thyrocyte HLA-DR antigen expression.

Authors:  A P Weetman; D J Volkman; K D Burman; T L Gerrard; A S Fauci
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

View more
  10 in total

1.  The distribution and possible function of gamma interferon-immunoreactive cells in normal endometrium and myometrium.

Authors:  C J Stewart; M A Farquharson; A K Foulis
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.

Authors:  S Fais; F Delle Fratte; F Mancini; V Cioni; M Guadagno; G Vetrano; F Pallone
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 3.  Cell mediated immunity in infertility.

Authors:  P Mallmann; K Diedrich
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

4.  Phenotypic characterization of inflammatory cells in phlyctenular eye disease.

Authors:  A M abu el-Asrar; J J Van den Oord; K Geboes; F Facchetti; L Missotten; M H Emarah; V Desmet
Journal:  Doc Ophthalmol       Date:  1988-12       Impact factor: 2.379

5.  Immunopathology of trachomatous conjunctivitis.

Authors:  A M el-Asrar; J J Van den Oord; K Geboes; L Missotten; M H Emarah; V Desmet
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

6.  Human endometrial epithelial cell lines for studying steroid and cytokine actions.

Authors:  S Tabibzadeh; K L Kaffka; P L Kilian; P G Satyaswaroop
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

7.  Expression of MHC class II antigens and immunoglobulin M by the corneal epithelial cells in herpetic keratitis.

Authors:  A M Abu el-Asrar; K Geboes; L Missotten; M H Emarah; V Desmet
Journal:  Int Ophthalmol       Date:  1990-07       Impact factor: 2.031

8.  Induction of MHC class II antigens on rat bronchial epithelial cells by interferon-gamma and its effect on antigen presentation.

Authors:  T Suda; A Sato; W Sugiura; K Chida
Journal:  Lung       Date:  1995       Impact factor: 2.584

9.  Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines.

Authors:  A C Menge; J Mestecky
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

10.  In situ hybridization for cytomegalovirus DNA in AIDS patients.

Authors:  W C Keh; M A Gerber
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.